The Trump administration’s overarching message to the legions of people powering the federal government is simple: Leave.
The U.S. Food and Drug Administration (FDA) has given its second most serious risk level, Class II, to a product from D. Coluccio & Sons. The recalled product is a 300 gram pack of chocolate chip ...
The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...
A clinical trial comparing a one-page medication handout proposed by the U.S. Food and Drug Administration (FDA) with an ...
The U.S. Food and Drug Administration is warning retailers and restaurants not to sell certain oysters that could be ...
The drugmaker expects the regulator to remove Wegovy and Ozempic from its shortage list, blocking other companies from ...
The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company ...
The U.S. Food and Drug Administration has labeled the broccoli recall as a Class I, the highest risk level issued by the agency.
AbbVie received Food and Drug Administration approval of Emblaveo, an intravenous antibiotic, for treatment of adults with complicated intra-abdominal infections with limited or no treatment options.
Going forward, we may see more instances in which insurers deny or (temporarily) severely restrict coverage of accelerated ...
These risks prompted California to ban its use in food in 2023 and the Food and Drug Administration to ban its use in both ..
The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.